ClinicalTrials.gg
RecruitingNCT07115186EASYUpdated Aug 11, 2025

School-Based Intervention to Enhance Resilience and Stress Coping in Rural Chinese Adolescents

An interventional study of Psychoeducation and guided written therapy in Stress, Emotional and Stress-related Mental Disorders, sponsored by Peking University. Recruiting at 1 site in China. Open to participants aged 10 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-11.

Sponsored by Peking University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as recruiting.
  • Started May 2025; still recruiting 1 year 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
850
Allocation
Randomized
Ages
10 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 28 studies in Stress, Psychological with a site in China — 9 open to participants now, 11 under way, none of them phase 3. Stress, Psychological · China.

Planned enrollment
2nd of 19
850 · median 126
Started
2025
with 4 others
No phase
18 of 28
4 open now
Primary completion
2026-06
later than 7 of 10 live
Registered
21st of 28
by date
Lead sponsor
3 of 28
Peking University

Among the 28 studies in Stress, Psychological with a site in China, this one is the 2nd largest by planned enrollment of the 19 interventional ones that give a count, is one of 5 that started in 2025, is one of 18 with no phase, reaches primary completion later than 7 of the 10 other live ones, and was the 21st registered.

Stress, Psychological

854 studies on the registry are indexed under Stress, Psychological; 141 are open to participants now.

Browse Stress, Psychological studies →

Open to participants now

9 of the 28 studies in Stress, Psychological with a site in China are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 74 Stress, Psychological studies recruiting now, 34 (46%) set no upper age limit and 36 (49%) stop at 75 or younger; 13 take children under 18; 49 take healthy volunteers.

This study: 10 Years to 18 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 28 studies in Stress, Psychological with a site in China, or all of them as a file.
02

Study summary

This study aims to evaluate the effectiveness of school-based psychological interventions in improving stress resilience and coping skills among adolescents in rural China. The intervention seeks to reduce stress-related mental health symptoms, including depression, anxiety, and post-traumatic stress, measured using validated instruments such as the Patient Health Questionnaire-9 (PHQ-9), the Generalized Anxiety Disorder 7-item scale (GAD-7), and the Child PTSD Symptom Scale for DSM-5 (CPSS-5). (See Appendix for full scale descriptions.)

Participants will be recruited from rural middle schools and randomly assigned to either an intervention group or a wait-list control group. The intervention consists of four sessions delivered over one week. Assessments will be conducted at baseline, immediately after the intervention, and again at a 3-month and 6-month follow-ups.

Researchers will use multilevel modeling (MLM) and structural equation modeling (SEM) to examine potential mediators and moderators of intervention effects, including emotion recognition, alexithymia, and coping strategies. indings are expected to provide evidence on the effectiveness and mechanisms of an existing, school-based psychological intervention tailored to the needs of adolescents in underserved rural settings.

03

Conditions studied

  • Stress, Emotional
  • Stress-related Mental Disorders

Keywords

  • adolescents
  • randomized controlled trial
  • PTSD
  • depression
  • anxiety
  • stress-related mental disorders
  • rural area
04

Who can participate

Ages eligible
10 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Currently enrolled middle school students attending regular school classes
  • Sufficient functional capacity in hearing, speaking, reading, and writing to participate in intervention activities and assessments.

Exclusion criteria

Exclusion Criteria:

  • Individuals assessed to be at high risk of suicide, based on screening or clinical judgment
  • Diagnosis of severe mental disorders (e.g., psychotic disorders, severe mood disorders) that would interfere with participation or require more intensive clinical care
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
850 participants (estimated)

Study arms

  • Active comparator
    TAU + delayed intervention

    Participants in this group will receive treatment as usual (TAU), which includes standard school-based support services. They will not receive the study intervention during the trial period but will be offered the full intervention after final outcome assessments. This design enables comparison between the intervention and existing standard care, while ensuring ethical access to the intervention for all participants.

    Behavioral: wait-list condition

  • Experimental
    intervention group

    Participants in the intervention group will receive a structured psychological program consisting of four sessions delivered over the course of one week. Each session is 40 minutes in duration and includes approximately 20 minutes of psychoeducation followed by 20 minutes of a guided writing intervention. The sessions will cover the following core themes: ① chronic stress and emotional regulation, ② emotional identification and acceptance, ③ cognitive emotion regulation, and ④ the cognitive triangle. Interventions will be administered by trained graduate students in clinical psychology from Peking University. These facilitators will receive specialized training on the intervention protocol, and will conduct pre-intervention assessments and participate in regular supervision. All sessions will be audio and video recorded to monitor treatment fidelity, ensure adherence to the intervention manual, and support supervision and quality assurance procedures.

    Behavioral: Psychoeducation · Behavioral: guided written therapy

Interventions

  • BehavioralPsychoeducation

    Psychoeducation sessions for adolescents focus on essential topics like stress, emotional distress, and mental disorders, offering foundational knowledge to enhance their understanding and ability to manage these challenges effectively.

  • Behavioralguided written therapy

    In the guided writing intervention, students are asked to write about a recent event that triggered strong emotions on paper and, based on the requirements of each session, attempt to regulate their emotions. This approach aims to enhance students' abilities in emotional identification and emotion regulation.

  • Behavioralwait-list condition

    Participants will engage in their regular school activities, and after the intervention group completes the program, they will receive the same intervention content as the intervention group.

06

What researchers measure

Primary outcomes

  1. PTSD for adolescents

    The Child PTSD Symptom Scale for DSM-5 (CPSS-5) for adolescents and children (scores from 0 to 4, and total scores vary from 0 to 80). A higher score represents worse PTSD symptoms.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  2. Depression

    The 9-item patient health questionnaire (PHQ-9) for adults (score ranges from 0 to 3, and the total score varies from 0 to 27). A higher score indicates worse depression symptoms.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  3. Insomnia Severity

    The severity of insomnia symptoms will be assessed using the Insomnia Severity Index (ISI). This 7-item self-report measurement evaluates the severity of insomnia symptoms, the level of satisfaction with sleep, interference with daily functioning, noticeability of impairment attributed to sleep problems, and the level of distress caused by sleep disturbance (score from 0 to 4, and total score vary from 0 to 32). Each item is rated on a 5-point scale, providing a comprehensive measure of insomnia severity.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  4. Generalized anxiety disorder

    The Generalized Anxiety Disorder-7 scale (GAD-7) for adults, adolescents, and children (scored from 0 to 3, and total score from 0 to 21). A higher score represents worse anxiety symptoms.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  5. Alexithymia

    A 22-item Peking alexithymia scale measures thoughts and behaviors that prevent people from feeling or recognizing negative emotions on a 5-point Likert scale (1 to 5, and total scores vary from 22 to 110). A higher score represents more severe alexithymia.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  6. Emotion awareness

    A 30-item Emotion awareness questionnaire measures emotion awareness on a 3-point Likert scale (1 to 3, with total scores ranging from 30 to 90). A higher score indicates better emotion awareness.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

Secondary outcomes

  1. Resilience

    The Connor-Davidson resilience scale is a 10-item resilience measurement scale that measures resilience on a 5-point Likert scale (scores range from 0 to 4, and the total score varies from 0 to 40). A higher score represents better resilience.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  2. Self-esteem

    A 10-item self-esteem measurement scale, Rosenberg self-esteem scale, measures self-esteem on a 4-point Likert scale (score from 0 to 3, and total score varies from 0 to 30), with higher scores indicating greater self-esteem.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  3. Subjective Happiness Scale

    A 4-item subjective happiness scale measures happiness (score from 1 to 7, and total score vary from 4 to 28). A higher score represents a happier state.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  4. Frustration

    The 25-item frustration scale (score from 1 to 5, and total score varies from 24 to 120). A higher score represents less frustration.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  5. Irritability

    A 17-item irritability measurement scale, the Peking irritability scale, measures impulsive emotions, thoughts, and behaviors on a 5-point Likert scale (score from 1 to 5, and total score varies from 17 to 85). A higher score represents higher irritability.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  6. Cognitive emotion regulation

    An 18-item cognitive emotion regulation questionnaire measures the ability of emotion regulation on a 5-point Likert scale (1 to 5, and total scores vary from 18 to 90). A higher score represents more emotion regulation.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  7. Game Addiction Scale

    A 7-item game addiction scale measures game addiction on a 5-point Likert scale (score from 1 to 5, and total score varies from 7 to 35), with higher scores indicating worse game addiction.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

Other outcomes

  1. Suicide

    The suicidal behaviors questionnaire-revised (SBQ-R) for adolescents and children (total scores vary from 3 to 18). A higher score represents a higher suicide risk.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  2. Subjective Units of Distress Scale

    A single item inquires about subjective distress on a 100-point scale. A higher score represents more subjective distress.

    Time frame: During intervention (up to 4 days)

  3. Behavior performances

    A 22-item behavior performance questionnaire measures various behavior performances such as study time, phone use, school performance, drinking alcohol, smoking, stealing, fighting, and lying.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  4. Adverse Childhood Experiences

    A 33-item adverse events questionnaire asks about adverse events before 18, including self-harm, experiencing emotional abuse, experiencing physical abuse, feeling severe distress, mental illness events (e.g., panic attack), and physical injury, etc. The score of each item ranges from 0 to 1(0=no, 1=yes), 0 to 4, or 0 to 5 (a higher score indicates a more severe adverse event)

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  5. Meaning in life

    A 6-item meaning in life scale measures life meaning (score from 1 to 5, and total score varies from 6 to 30). A higher score represents a more life-meaning perception.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  6. Non-suicidal self-injury

    The non-suicidal self-injury assessment tool (NSSI-AT-Severity) for adolescents and children (total scores vary from 5 to 16). A higher score represents a worse self-injury situation.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  7. Somatic problems

    A somatic problems scale modified from PHQ-15, measuring various physical discomforts and pain on a 3-point Likert scale (score from 0 to 2). A higher score represents worse somatic problems.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  8. EQ-5D-3L

    The EQ-5D-3L was developed by EuroQol to measure the health-related quality of life with 6 items. The 1\~5 items are coded from 1 to 5, and the last item scores from 1 to 100. The scale will then be calculated into a value for further calculation of quality-adjusted life-years (QALYs), which will be used in the cost-effectiveness analysis.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  9. Seeking for help

    A 10-item help-seeking scale measures on a 7-point Likert scale (score from 1 to 7, and total score varies from 10 to 70), with higher scores indicating greater willingness to seek help from others.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  10. Positive Childhood Experiences

    A questionnaire measuring positive childhood experiences with 13 items(total scores vary from 0 to 64). A higher score represents a more positive childhood experience.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  11. Social support

    The 12-item Multidimensional Scale of Perceived Social Support (score from 1 to 7, and total score varies from 12 to 84). A higher score represents better social support.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  12. Adverse events during RCT

    A 6-item adverse events during RCT scale measures adverse events (score from 0 to 1, and total score varies from 0 to 6). A higher score represents adverse events.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  13. Parent-adolescent relationship

    A 6-item parent-adolescent relationship scale measures parent-adolescent relationship (score from 0 to 4, and total score varies from 0 to 24). A higher score represents better parent-adolescent relationship.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  14. Shame

    An 8-item shame scale measures shame (score from 0 to 4, and total score varies from 0 to 32). A higher score represents more shame.

    Time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

07

Study locations

1 of 1 sites recruiting
  • Biancun middle school
    Hebei, Baoding 071603, China
    Recruiting
    • Liang Yachai · Contact86+ 03125217599
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2025 (actual). Primary completion is estimated for Jun 2026, 12 months after the start.

Of 462 non-industry interventional studies with no phase under Stress, Psychological, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's planned 12 months is close to that.

Counting every sponsor, half of 475 studies reached it within 13 months; a quarter within 5 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
May 12, 2025
First posted
Aug 11, 2025
StartActual
May 12, 2025
Primary completionEst.
Jun 1, 2026
CompletionEst.
Dec 31, 2026
Last update
Aug 11, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07115186
Lead sponsor
Peking University
Responsible party
Yinyin Zang, PhD (Principal Investigator, Peking University) — Principal investigator
First posted
Aug 11, 2025
Start date
May 12, 2025
Primary completion
Jun 1, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Aug 11, 2025

Study contacts

Zang Yinyin, PhD
Contact
yinyin.zang@pku.edu.cn
+86 15553201610
Feng Junkai, MSc
Contact
86+15625013745

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion